Ed Egilinsky, managing director, head of sales and distribution and alternatives at Direxion, offers some advice to investors on how to position their portfolio for retail earnings.
The Trump administration has issued its first warnings to online services that offer unofficial versions of popular drugs like the blockbuster obesity treatment Wegovy.
Oracle soars as it cashes in on the AI boom, Plus: Starbucks shares continue to fall under its new CEO, and does anybody actually want a new iPhone Air?
